Twist Bioscience Corp is a leading synthetic biology company in the Pharmaceuticals industry based in the United States. With an ESG score of 25.5, it is considered a medium-risk investment. The company is known for its disruptive DNA synthesis platform that revolutionizes the engineering of biology. Using a patented semiconductor-based process, Twist Bioscience Corp can produce high-quality synthetic DNA faster and more affordably than traditional methods. This allows for cost-effective, rapid high-throughput synthesis, empowering researchers to capitalize on new opportunities quickly. The majority of its revenue comes from the United States.